Expression of MMP-2, MMP-9, and urokinase-type plasminogen activator in cervical intraepithelial neoplasia

Jae Hong No, Hoenil Jo, Su Hyeong Kim, In Ae Park, Daehee Kang, Chae Hyeong Lee, Seung Su Han, Jae Weon Kim, Noh Hyun Park, Soon Beom Kang, Yong Sang Song

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

18 Scopus citations


Matrix metalloproteinase-2 (MMP-2), MMP-9, and urokinase-type plasminogen activator (uPA) are important factors for cancer invasion and metastasis, degrading the extracellular matrix. They are also associated with angiogenesis. Angiogenic phenotype is another feature of high-grade cervical intraepithelial neoplasia (CIN). However, their associations with the progression of low-grade CIN to high-grade CIN are unexplored. We investigated whether these proteolytic enzyme expressions correlate with the progression of CIN. A total of 39 paraffin-embedded specimens from 10 patients with CIN grade 1, nine with CIN grade 2, and 20 with CIN grade 3 were assessed immunohistochemically by specific antibodies against MMP-2, MMP-9, and uPA. MMP-9 expression was higher in CIN 3 lesions (47.4%) than in CIN 1 (22.2%) and CIN 2 (20.2%) lesions, although the difference failed to reach statistical significance. The expression level of uPA and MMP-2 was not associated with the grade of CIN lesions. Interestingly, we found a significant association between expressions of uPA and MMP-2 (P = 0.028). Our results suggest that MMP-9 might play a role in the progression of CIN.

Original languageEnglish
Title of host publicationNatural Compounds and Their Role in Apoptotic Cell Signaling Pathways
PublisherBlackwell Publishing Inc.
Number of pages5
ISBN (Print)9781573317375
StatePublished - Aug 2009

Publication series

NameAnnals of the New York Academy of Sciences
ISSN (Print)0077-8923
ISSN (Electronic)1749-6632


  • Cervical intraepithelial neoplasia
  • Matrix metalloproteinase
  • Urokinase-type plasminogen activator


Dive into the research topics of 'Expression of MMP-2, MMP-9, and urokinase-type plasminogen activator in cervical intraepithelial neoplasia'. Together they form a unique fingerprint.

Cite this